View Author
r-tau 4 r-tau disease sample assay cerebrospinal fl uid level control p-tau alzheimer isoform cohort elisa centre cerebrospinal arti ficial csf neurochemistry © 2012 supranuclear palsy difference brain biomarker value patient laboratory neurology dementia ratio neurochemistry study buffer university 3 r-tau authors journal variation signi variability sample dilution buffer protein concentration signi ficantly corticobasal degeneration author strip measurement t-tau analysis supranuclear ficial tau isoforms palsy comparison intercv innotestw 10 pg /ml intercentre 4 r-tau isoforms diagnosis blennow tauopathie department neurochem figure pathology criteria marker corticobasal result dilution 4 r-tau levels min – max parkinson arti ficial csfs rd 4 antibodies journal 0 pg /ml society detection degeneration neurol amyloid
2 Most Recent Publications
|
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
(Article)
Luk, C. Compta, Y. Trenkwalder, C. Swieten, J.C. van Chiu, W.Z. Borroni, B. Cámara, A. Cheshire, P. Williams, D.R. Lees, A.J. Silva, R. de Magdalinou, N. Martí, M.J. Hondhamuni, G. Zetterberg, H. Blennow, K. Constantinescu, R. Pijnenburg, Y. Mollenhauer, B. |
2012-11-01
|
|
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
(Article)
Verwey, N.A. Flier, W.M. van der Lannfelt, L. Mehta, P.D. Parnetti, L. Petzold, A. Pirttilä, T. Saleh, L. Skinningsrud, A. Swieten, J.C. van Verbeek, M.M. Wiltfang, J. Blennow, K. Younkin, S. Scheltens, P. Blankenstein, M.A. Clark, C. Sokolow, S. Deyn, P.P. de Galasko, D. Hampel, H. Hartmann, J.T. Kapaki, E. |
2009-05-01
|